Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Buy at Erste Group Bank

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) was upgraded by equities researchers at Erste Group Bank from a "hold" rating to a "buy" rating in a report released on Thursday, MarketBeat.com reports.

Several other equities research analysts have also issued reports on the company. Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Truist Financial decreased their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Piper Sandler reduced their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Finally, Royal Bank of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Stock Down 0.2%

Shares of NASDAQ:ISRG traded down $0.98 during mid-day trading on Thursday, reaching $557.08. 1,103,774 shares of the stock were exchanged, compared to its average volume of 1,643,591. The company has a market cap of $199.67 billion, a P/E ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. The stock's 50 day simple moving average is $521.99 and its 200-day simple moving average is $539.16. Intuitive Surgical has a one year low of $413.52 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the firm posted $1.50 EPS. Analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares of the company's stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 25,443 shares of company stock worth $12,692,195 in the last three months. 0.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently added to or reduced their stakes in the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Global Financial Private Client LLC raised its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares during the last quarter. Finally, Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $26,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.